Omeros Corporation (OMER)
Omeros Corporation (OMER) is a healthcare company (biotechnology) based in the United States. The share price is $13.92, down 16.55% on the day, which values the company at $1.01B. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.
Key facts
- Share price
- $13.92−16.55% today
- Market value
- $1.01B
- P/E ratio
- 16.8×last 12 months
- Forward P/E
- 6.4×
- 200-week average
- $7.1196% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Omeros Corporation in more detail
OMER trades at 16.8× its last twelve months' earnings, 6.4× next year's expected earnings, 13.6× sales. It sits 96% above its 200-week average of $7.11.
Worth checking: Weak Piotroski score.
Omeros Corporation (OMER): questions and answers
What is OMER's P/E ratio?
Omeros Corporation trades at 16.8× its last twelve months' earnings and 6.4× next year's expected earnings.
What is OMER's PEG ratio?
Omeros Corporation's PEG ratio is 0.81 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Omeros Corporation's market cap?
Omeros Corporation is valued at $1.01B at a share price of $13.92.
Is OMER above its 200-week moving average?
Yes. OMER is 95.7% above its 200-week average of $7.11. Long-term investors watch that line because strong companies rarely trade below it for long.
Does OMER pay a dividend?
Omeros Corporation does not currently pay a regular dividend.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Omeros Corporation (OMER) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/OMER
Underlying data: Yahoo Finance; company filings with the SEC.